ARTICLE | Distillery Therapeutics
Therapeutics: Peptidyl arginine deiminase type IV (PADI4; PAD4)
February 19, 2015 8:00 AM UTC
In vitro studies have identified selective, reversible PADI4 inhibitors that could be help treat various autoimmune and cardiovascular diseases. In vitro assays identified two PADI4 inhibitors that se...